Variant report

Variant	esv3398749
Chromosome Location	chr21:40030382-40034780
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr21:40033470-40033725	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr21:40032298-40033018	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr21:40033114-40033338	HepG2	liver:	n/a	n/a
4	CEBPB	chr21:40033873-40034214	IMR90	lung:	n/a	n/a
5	CEBPB	chr21:40033139-40033386	IMR90	lung:	n/a	n/a
6	CEBPB	chr21:40033087-40033424	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr21:40033401-40033511	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr21:40032103-40033755	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr21:40032407-40032501	Fibrobl	skin:	n/a	n/a
10	CTCF	chr21:40033440-40033590	GM12871	blood:	n/a	n/a
11	E2F6	chr21:40032297-40033764	H1-hESC	embryonic stem cell:	n/a	chr21:40032692-40032701 chr21:40032506-40032515
12	E2F6	chr21:40032301-40033673	H1-hESC	embryonic stem cell:	n/a	chr21:40032692-40032701 chr21:40032506-40032515
13	EGR1	chr21:40032519-40033160	MCF-7	breast:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
14	EGR1	chr21:40032426-40033060	ECC-1	luminal epithelium:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
15	EGR1	chr21:40032555-40032878	K562	blood:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
16	EGR1	chr21:40032477-40033111	ECC-1	luminal epithelium:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
17	EGR1	chr21:40032494-40033110	H1-hESC	embryonic stem cell:	n/a	chr21:40032687-40032700 chr21:40032692-40032702
18	ELK1	chr21:40033918-40033922	GM12878	blood:	n/a	n/a
19	FOXA1	chr21:40033824-40034147	HepG2	liver:	n/a	n/a
20	HA-E2F1	chr21:40032583-40033554	MCF-7	breast:	n/a	chr21:40032692-40032701
21	HDAC2	chr21:40032388-40033119	H1-hESC	embryonic stem cell:	n/a	n/a
22	HDAC2	chr21:40032516-40033158	MCF-7	breast:	n/a	n/a
23	HDAC2	chr21:40032631-40032920	H1-hESC	embryonic stem cell:	n/a	n/a
24	MAX	chr21:40032192-40033108	ECC-1	luminal epithelium:	n/a	chr21:40032227-40032237 chr21:40032425-40032434
25	MAX	chr21:40033136-40033674	A549	lung:	n/a	chr21:40033420-40033427
26	MAX	chr21:40032255-40033077	ECC-1	luminal epithelium:	n/a	chr21:40032425-40032434
27	MAX	chr21:40032780-40033689	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427
28	MAX	chr21:40033154-40033521	ECC-1	luminal epithelium:	n/a	chr21:40033420-40033427
29	MAX	chr21:40033144-40033556	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427
30	MAX	chr21:40032486-40033693	MCF-7	breast:	n/a	chr21:40033420-40033427
31	MAX	chr21:40033230-40033601	A549	lung:	n/a	chr21:40033420-40033427
32	MAX	chr21:40032251-40033696	H1-hESC	embryonic stem cell:	n/a	chr21:40033420-40033427 chr21:40032425-40032434
33	MAX	chr21:40033362-40033562	A549	lung:	n/a	chr21:40033420-40033427
34	MXI1	chr21:40032419-40032530	H1-hESC	embryonic stem cell:	n/a	n/a
35	MXI1	chr21:40033279-40033399	H1-hESC	embryonic stem cell:	n/a	n/a
36	MYC	chr21:40033329-40033487	MCF-7	breast:	n/a	chr21:40033420-40033427
37	MYC	chr21:40033379-40033413	MCF-7	breast:	n/a	n/a
38	MYC	chr21:40032663-40032889	MCF-7	breast:	n/a	n/a
39	MYC	chr21:40032418-40032596	MCF-7	breast:	n/a	chr21:40032425-40032434
40	MYC	chr21:40033249-40033296	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr21:40032902-40033619	H1-neurons	neurons:	n/a	n/a
42	POLR2A	chr21:40033052-40033677	H1-neurons	neurons:	n/a	n/a
43	POLR2A	chr21:40032604-40033159	HL-60	blood:	n/a	n/a
44	POLR2A	chr21:40033417-40033419	MCF-7	breast:	n/a	n/a
45	POLR2A	chr21:40032786-40033097	MCF-7	breast:	n/a	n/a
46	POLR2A	chr21:40032753-40032756	MCF-7	breast:	n/a	n/a
47	POLR2A	chr21:40032384-40032847	H1-neurons	neurons:	n/a	n/a
48	POLR2A	chr21:40032720-40033131	ProgFib	skin:	n/a	n/a
49	POLR2A	chr21:40032760-40033178	MCF-7	breast:	n/a	n/a
50	PRDM1	chr21:40033833-40034187	Hela-S3	cervix:	n/a	chr21:40034015-40034030 chr21:40034016-40034030 chr21:40034017-40034026

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:40033892-40033942	HEK293	kidney:	embryo
2	chr21:40033892-40033942	HEK293	kidney:	embryo
3	chr21:40033163-40033213	MCF-7	breast:	n/a
4	chr21:40033634-40033684	GM19239	blood:	n/a
5	chr21:40033634-40033684	HRPEpiC	eye:	n/a
6	chr21:40033163-40033213	HRPEpiC	eye:	n/a
7	chr21:40033163-40033213	NHDF-neo	bronchial:	n/a
8	chr21:40033154-40033204	SK-N-SH_RA	brain:	n/a
9	chr21:40033892-40033942	MCF-7	breast:	n/a
10	chr21:40031353-40031403	GM12892	blood:	n/a
11	chr21:40031295-40031345	HIPEpiC	eye:	n/a
12	chr21:40031353-40031403	HPAEpiC	pulmonary alveolar:	n/a
13	chr21:40031353-40031403	Hela-S3	cervix:	n/a
14	chr21:40033154-40033204	GM12892	blood:	n/a
15	chr21:40033154-40033204	SK-N-MC	brain:	n/a
16	chr21:40033634-40033684	AG04449	skin:	fetal
17	chr21:40034771-40034821	SK-N-SH_RA	brain:	n/a
18	chr21:40033634-40033684	IMR90	lung:	fetal
19	chr21:40033634-40033684	AG09309	skin:	n/a
20	chr21:40033154-40033204	HRE	kidney:	n/a
21	chr21:40031353-40031403	NT2-D1	testis:	n/a
22	chr21:40033163-40033213	ECC-1	luminal epithelium:	n/a
23	chr21:40034771-40034821	NHBE	bronchial:	n/a
24	chr21:40031295-40031345	Hepatocyte	liver:	n/a
25	chr21:40031295-40031345	HCM	heart:	n/a
26	chr21:40033163-40033213	T-47D	breast:	n/a
27	chr21:40031295-40031345	NB4	blood:	n/a
28	chr21:40031295-40031345	HRPEpiC	eye:	n/a
29	chr21:40031353-40031403	HCPEpiC	choroid plexus:	n/a
30	chr21:40031295-40031345	HCPEpiC	choroid plexus:	n/a
31	chr21:40033892-40033942	IMR90	lung:	fetal
32	chr21:40031353-40031403	HRPEpiC	eye:	n/a
33	chr21:40033634-40033684	GM12892	blood:	n/a
34	chr21:40032331-40032381	SK-N-SH_RA	brain:	n/a
35	chr21:40033892-40033942	GM12891	blood:	n/a
36	chr21:40031295-40031345	PFSK-1	brain:	n/a
37	chr21:40034771-40034821	NB4	blood:	n/a
38	chr21:40034771-40034821	U87	brain:	n/a
39	chr21:40031295-40031345	RPTEC	kidney:	n/a
40	chr21:40032331-40032381	AG10803	skin:	n/a
41	chr21:40031295-40031345	SKMC	muscle:	n/a
42	chr21:40032331-40032381	ovcar-3	ovarian:	n/a
43	chr21:40034771-40034821	A549	lung:	n/a
44	chr21:40033634-40033684	SKMC	muscle:	n/a
45	chr21:40033154-40033204	NB4	blood:	n/a
46	chr21:40031295-40031345	SK-N-SH_RA	brain:	n/a
47	chr21:40031295-40031345	SK-N-MC	brain:	n/a
48	chr21:40032331-40032381	HEEpiC	esophagus:	n/a
49	chr21:40034771-40034821	HepG2	liver:	n/a
50	chr21:40033634-40033684	Hela-S3	cervix:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr21:40032723..40034705-chr21:40552796..40555245,2	MCF-7	breast:
2	chr21:40030626..40032570-chr21:40036833..40038338,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DSCR4-16	chr21:40033582-40033618	NONHSAT082106

Variant related genes	Relation type
ERG	TF binding region
ERG	CpG island
ENSG00000183527	chromatin interactions

Extended variants
information (count: 141 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:141 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs551775873	chr21:40030396-40030397	Bivalent Enhancer Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs538199024	chr21:40030403-40030404	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs568086445	chr21:40030404-40030405	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs558027958	chr21:40030406-40030407	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs145470153	chr21:40030415-40030416	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs73446348	chr21:40030429-40030430	Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs4143428	chr21:40030582-40030583	Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs574078328	chr21:40030608-40030609	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs371156792	chr21:40030627-40030628	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs561639561	chr21:40030649-40030650	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs543091691	chr21:40030673-40030674	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs561773050	chr21:40030692-40030693	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs530727198	chr21:40030728-40030729	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs185983247	chr21:40030747-40030748	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs115389376	chr21:40030872-40030873	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs138019685	chr21:40030901-40030902	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs546638000	chr21:40030933-40030934	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs566444784	chr21:40030994-40030995	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs529015492	chr21:40031065-40031066	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs1015748	chr21:40031111-40031112	Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs149544231	chr21:40031128-40031129	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs538437667	chr21:40031194-40031195	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs190590315	chr21:40031259-40031260	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs571624309	chr21:40031269-40031270	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs574894407	chr21:40031277-40031278	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs370062974	chr21:40031287-40031288	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs182321362	chr21:40031313-40031314	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs34638227	chr21:40031314-40031315	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs573967995	chr21:40031412-40031413	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs114965716	chr21:40031432-40031433	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs186002293	chr21:40031444-40031445	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs556619697	chr21:40031449-40031450	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs374860284	chr21:40031459-40031460	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs544432326	chr21:40031578-40031579	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs143177959	chr21:40031595-40031596	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs148205077	chr21:40031647-40031648	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs540519659	chr21:40031737-40031738	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs559935939	chr21:40031845-40031846	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs528879895	chr21:40031847-40031848	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs75897329	chr21:40031896-40031897	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs76590500	chr21:40031901-40031902	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs78389852	chr21:40031902-40031903	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs9647180	chr21:40031924-40031925	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs72394651	chr21:40031967-40031968	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs376955072	chr21:40031968-40031969	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs571492163	chr21:40032006-40032007	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs115101815	chr21:40032009-40032010	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs554039131	chr21:40032011-40032012	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs567816289	chr21:40032019-40032020	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs543997898	chr21:40032040-40032041	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Acute myeloid leukemia	17237825	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Down syndrome	20877625	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Prostate cancer	21147910	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Prostate cancer	20562851	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:40028600-40031000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr21:40028800-40034400	Active TSS	Breast Myoepithelial Primary Cells	Breast
3	chr21:40029800-40034600	Active TSS	Aorta	Aorta
4	chr21:40030000-40030400	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr21:40030000-40030400	Bivalent Enhancer	Osteobl	bone
6	chr21:40031000-40031200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr21:40031200-40031800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr21:40031200-40034400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr21:40031400-40033800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
10	chr21:40031600-40031800	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
11	chr21:40031600-40031800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
12	chr21:40031600-40032000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
13	chr21:40031600-40032000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
14	chr21:40031800-40032000	Bivalent Enhancer	Primary hematopoietic stem cells	blood
15	chr21:40031800-40032000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr21:40031800-40032000	Bivalent Enhancer	Thymus	Thymus
17	chr21:40031800-40032200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
18	chr21:40031800-40032200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
19	chr21:40031800-40032400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr21:40031800-40033000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
21	chr21:40031800-40033200	Bivalent/Poised TSS	Osteobl	bone
22	chr21:40031800-40033600	Flanking Bivalent TSS/Enh	Primary neutrophils fromperipheralblood	blood
23	chr21:40031800-40034000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
24	chr21:40031800-40034000	Bivalent/Poised TSS	Primary T cells from cord blood	blood
25	chr21:40031800-40034000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
26	chr21:40031800-40034200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
27	chr21:40032000-40032200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
28	chr21:40032000-40032200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr21:40032000-40032200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr21:40032000-40032200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr21:40032000-40032200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
32	chr21:40032000-40032200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
33	chr21:40032000-40032200	Enhancers	Esophagus	oesophagus
34	chr21:40032000-40032200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
35	chr21:40032000-40032200	Bivalent Enhancer	Fetal Stomach	stomach
36	chr21:40032000-40032200	Enhancers	Lung	lung
37	chr21:40032000-40032200	Bivalent Enhancer	Right Ventricle	heart
38	chr21:40032000-40032400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr21:40032000-40032400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
40	chr21:40032000-40032400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
41	chr21:40032000-40032400	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr21:40032000-40032600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
43	chr21:40032000-40032600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr21:40032000-40032800	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr21:40032000-40032800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
46	chr21:40032000-40032800	Bivalent Enhancer	Placenta	Placenta
47	chr21:40032000-40032800	Bivalent Enhancer	Fetal Thymus	thymus
48	chr21:40032000-40033200	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
49	chr21:40032000-40033200	Flanking Bivalent TSS/Enh	Thymus	Thymus
50	chr21:40032000-40033600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links